Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shivani Srivastava, M.D.
Hoosier Cancer Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
- Community Regional Cancer Center
Indianapolis, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Arnett Cancer Care
Lafayette, Indiana, United States
- Virtua Health Cancer Program
Mount Holly, New Jersey, United States
- South Jersey Health Care
Vineland, New Jersey, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Case Comprehensive Cancer Center - University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Seidman Cancer Center
Cleveland, Ohio, United States
- Reading Hospital Regional Cancer Center
West Reading, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 31 Oct 2013
- Completion
- 31 Oct 2013
- Last update posted
- 24 Oct 2016
- Registered enrollment
- 4
- Registry id
- NCT01186458
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.